Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it

Author:

Núñez-Jaramillo Luis1ORCID,Herrera-Morales Wendy Verónica1ORCID,Ramírez-Lugo Leticia2ORCID,Cauich-Kumul Roger3ORCID,Murillo-Rodríguez Eric45ORCID

Affiliation:

1. Departamento de Ciencias Médicas, División de Ciencias de la Salud, Universidad de Quintana Roo, Chetumal, Quintana Roo, México

2. Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, México

3. Departamento de Ciencias Farmaceúticas, División de Ciencias de la Salud, Universidad de Quintana Roo, Chetumal, Quintana Roo, México

4. Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina, División Ciencias de la Salud, Universidad Anáhuac Mayab Mérida, México

5. Intercontinental Neuroscience Research Group, Mérida, Yucatán, México

Abstract

Abstract: Attention-deficit hyperactivity disorder is a neurodevelopmental disorder diagnosed primarily in children, although it is also present in adults. Patients present inattention, impulsivity, and hyperactivity symptoms that create difficulties in their daily lives. Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms. Although generally effective and safe, pharmacological treatments have different effects among patients, including lack of response and adverse reactions. The reasons for these differences are not fully understood, but they may derive from the highly diverse etiology of ADHD. Strategies to guide optimal pharmacological treatment selection based on individual patients’ physiological markers are being developed. In this review, we describe the main pharmacological ADHD treatments used and their main drawbacks. We present alternatives under study that would allow the customization of pharmacological treatments to overcome these drawbacks and achieve more reliable improvement of ADHD symptoms.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3